youtube
#Astellas #YASKAWAElectric #AIDrugDiscovery #AI #robotics #celltherapy #regeneretivemedicine #innovation #PatientCare #healthcare #science
What if the solution to cell therapy's "valley of death" was a partnership between humans, AI and robots?
To tackle this challenge, Astellas and YASKAWA Electric formed Cellafa Biosciences. Their mission is to build a global platform that expands patient access to life-changing treatments.
Hear from the architects of this venture—Cellafa's CEO Hideto Yamaguchi and Astellas' Jotaro Suzuki—as they share their vision for the future of cell therapy.
Read the full story:
|
